BSE filing, NSE: JSLINDL. Summary written from the filing by ALFA Finder's alert engine.
JSL Industries Ltd: key numbers
- Share price
- ₹809.00
- Market cap
- ₹94.97 Cr
- Revenue (annual)
- ₹56.43 Cr
- Net profit (annual)
- ₹3.29 Cr
- P/E (TTM)
- 28.6×Sector 41.7×
- Promoter holding
- 40.58%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from JSL Industries Ltd
All →JSL Industries Management Change
JSL Industries Limited has revised the relieving date for its Company Secretary and Compliance Officer to August 26, 2026. This change follows a mutual agreement with the employee.
JSL Industries Q1 FY27 Results: Net Profit ₹0.4 Cr, Up 0.0% YoY
JSL Industries Ltd reported revenue from operations of ₹14.5 Cr (+18.9% YoY) and net profit of ₹0.4 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.4 Cr · +0.0% YoY
JSL Industries Board Meeting Date
JSL Industries Limited has scheduled a board meeting for August 13, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.
JSL Industries Annual General Meeting
JSL Industries held its 60th AGM on July 7 2026, adopting audited FY-2026 results and declaring a preference-share dividend. Directors were re-appointed and a related-party transaction was approved.
JSL Industries Annual Report
JSL Industries Limited has submitted its 60th Annual Report for the financial year 2025-26. The company's Annual General Meeting is scheduled for July 07, 2026.
JSL Industries Annual General Meeting
JSL Industries Limited announced book closure from July 1 to July 7, 2026. The closure precedes the company's 60th Annual General Meeting.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.